Hillrom Advances Digital Health Offering With Expansion Into Attractive Ambulatory Cardiac Monitoring Segment CHICAGO, Jan. 19, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies. Under the terms of […]
Financial
DiNAQOR Acquires EHT Technologies GmbH to Advance Engineered Heart Tissue R&D Capabilities
PFÄFFIKON, Switzerland, Jan. 19, 2021 /PRNewswire/ — DiNAQOR, a gene therapy platform company, today announced that it has acquired EHT Technologies GmbH, a Germany-based engineered heart tissue (EHT) technology platform company. Financial terms of the transaction were not disclosed. EHT Technologies was founded in 2015 based upon research on human induced pluripotent stem cells (hiPSC) at […]
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders […]
CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer
EDEN PRAIRIE, Minn., Jan. 19, 2021 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo, Jr. to President and Chief Executive Officer (CEO), effective immediately. […]
ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program
– Fourth-quarter 2020 U.S. net product revenue estimated between $8.0 and $8.5 million – – Range represents over 140 percent sequential growth for NEXLETOL® (bempedoic acid) tablets and NEXLIZET® (bempedoic acid and ezetimibe) tablets – – Company provides full-year 2021 operating expense guidance – – In-licensed oral PCSK9 inhibitor program furthers ESPERION […]
Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results
CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. Preliminary Fourth Quarter and Full […]
Mentice to enhance its organization with several new key positions
STOCKHOLM, Jan. 13, 2021 /PRNewswire/ — Mentice AB (publ), a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization. Several new key positions have been created, aimed at improving Mentice’s regional presence in the market. Effective January 1st, Mentice has adopted a […]
Inari Medical Reports Preliminary Fourth Quarter 2020 Revenue
IRVINE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Inari Medical Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quarter 2020 revenue. Preliminary Fourth Quarter Revenue and Business Highlights: Preliminary unaudited […]
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer
Toland joins Andrew Cleeland (Chairman of the Board, MMI) in developing the field of robotic-assisted microsurgery CALCI, Italy, Jan. 12, 2021 /PRNewswire/ — Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the hiring of Mark Toland as Chief Executive Officer. He brings more than 25 years […]
Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate
ENGLEWOOD, Colo., Jan. 12, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q4 2020. Thomas Sandgaard, CEO of Zynex said: “We concluded 2020 with strong orders and posted […]


